Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE)
Catalog No.
F1839
Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE)
Featured Products
Lorvotuzumab-MMAE is a CHO-expressed humanized antibody targeting NCAM1/CD56.
145 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
lorvotuzumab-MMAE
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P13591
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
U251 Cell Line were stained with Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE) ) and negative control protein respectively, washed and then followed by PE and analyzed with FACS,The EC50 is 0.02 μg/mL.
NCAM1 / CD56
Please avoid freeze-thaw cycles.